Advisory board

International acknowlegded experts active in the fields of science, clinics and business development are members of the advisory board of oncgnostics.

Prof. Dr. Magnus von Knebel Doeberitz

Prof. Dr. Magnus von Knebel Doeberitz

Director applied tumor biology, university hospital Heidelberg

Besides his profession as the head of applied tumor biology, university hospital Heidelberg, Prof. von Knebel Doeberitz was co-founder of mtm laboratories, which was acquired by Roche Diagnostics in 2011. Therefore he has outstanding experience concerning positioning of tests especially in the field of cervical cancer diagnostics, where he is an interntionally renowned expert.

Dr. Christoph Petry

Dr. Christoph Petry

Dr. Christoph Petry has longterm experiences in the diagnostics business. As a PhD in Chemistry, he was Head of the diagnostic part of Bayer HealthCare AG and after that, Siemens Healthcare Diagnostics. Most recently he was CEO of the Sividon Diagnostics and has led the company from the time of founding to the successfull tradesale by Myriad Genetics in 2016.

Prof. Dr. Ingo B. Runnebaum

Prof. Dr. Ingo B. Runnebaum

Director women’s university hospital Jena

Prof. Dr. Ingo B. Runnebaum is gynecologist, researcher in cancer and reproductive medicine. Furthermore, he is university professor at the Friedrich-Schiller University Jena and director of the women’s hospital Jena with scientific focus on gynecological oncology, gynecological surgery and gynecological molecular biology. He is a recognized expert in the field of ovarian-, cervical- and breast cancer and an important cooperation partner of oncgnostics.

Consultants

Prof. Dr. Matthias Dürst

Prof. Dr. Matthias Dürst

Virologist, co-founder and scientific cooperation partner

Prof. Dürst heads the functional unit “Gynaecologic Molecular Biology” at the University women’s hospital Jena. He is a dedicated expert in the field of human papillomaviruses, carcinogenesis and HPV diagnostics. He has contributed substantially to the research that led to the award of the Nobel prize for medicine to Prof. Harald zur Hausen in 2008. Due to his long-lasting experience in virus-induced carcinogenesis and his contacts to the economy and science community he works as an advisor for oncgnostics.